AxoGen Inc (NASDAQ:AXGN)

10.73
Delayed Data
As of Sep 23
 -0.26 / -2.36%
Today’s Change
6.87
Today|||52-Week Range
16.75
+14.51%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$454.1M

Company Description

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm's products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Contact Information

AxoGen, Inc.
13631 Progress Boulevard
Alachua Florida 32615
P:(386) 462-6800
Investor Relations:

Employees

Shareholders

Other institutional44.53%
Mutual fund holders34.28%
Individual stakeholders25.21%

Top Executives

Karen L. ZaderejChairman, President & Chief Executive Officer
Mike DonovanVice President-Operations
Peter J. MarianiChief Financial Officer & Executive Vice President
Erick Wayne DeVinneyVice President-Clinical & Translational Sciences
Ivica DucicMedical Director